- Features
- Performances
- Specifications
- References
- Hirata et al.
- IMMUSORBA TR and PH.
- Ther Apher Dial. 7:85-90, 2003.
- Yoshida et al.
- IMMUSORBA TR and IMMUSORBA PH: Basics of design and features of functions.
- Ther Apher. 4:127-34, 2000.
- Gaubitz et al.
- Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus.
- J Autoimmun. 11:495-501, 1998.
- Yoshida et al.
- IMMUSORBA TR and IMMUSORBA PH: Basics of design and features of functions.
- Ther Apher. 4:127-34, 2000.
- Yang et al.
- Plasma adsorption in critical care.
- Ther Apher. 6:184-8, 2002.
- Hirata et al.
- IMMUSORBA TR and PH.
- Ther Apher Dial. 7:85-90, 2003.
- Sugimoto et al.
- Immunoadsorption plasmapheresis using a phenylalanine column as an effective treatment for lupus nephritis.
- Ther Apher Dial. 10:187-92, 2006.
- Yamaji et al.
- Long-term clinical outcomes of synchronized therapy with plasmapheresis and intravenous cyclophosphamide pulse therapy in the treatment of steroid-resistant lupus nephritis.
- Ther Apher Dial. 12:298-305, 2008.
- Loo et al.
- Immunoadsorption and plasmapheresis are equally efficacious as adjunctive therapies for severe lupus nephritis.
- Transfus Apher Sci. 43:335-40, 2010.
Trademark
IMMUSORBA is a trademark of Asahi Kasei Medical Co., Ltd.
![](/medical/en/apheresis/product/plasma/ph/img/img_download.jpg)
IMMUSORBA PH
Please feel free to send us any questions you may have about our products and support.
Share your feelings and experiences when using our products.